Life Sciences Disrupted: Accelerating Time to Market with Digital Supply Chain Innovation
What's this research about?
Life Sciences supply chains have become more global and complex than ever before. In the wake of the pandemic, the industry witnessed increased market and patient pressures to accelerate speed to market. The combination of these two trends raises a number of IT, manufacturing, supply chain, logistics and regulatory challenges that demand new, innovative thinking and solutions.
This peer-led research study seeks to open a dialogue between supply chain and IT leaders to explore how the industry can balance expectations for faster time to market responsiveness while maintaining supply chain integrity.
This research, sponsored by HCL Technologies, will feature the views and insights from 15 industry leaders on a range of vital topics, including how to scale digital technologies along the Life Sciences manufacturing and distribution value chains, how to ensure compliance in target markets, and how new technologies can help combat counterfeit drugs.
TechPros.io will be publishing an eBook containing insights from the interviews in March 2023.
Book your interview now*
Why participate in a TechPros.io interview?
SHARE. LEARN. CONNECT.
- Share your experiences and learn from others
- Find out what your industry peers think
- Be featured in a publication and on TechPros.io
- Raise awareness of your personal brand on LinkedIn
Book your interview:
Participation does not cost anything other than 30 minutes of your time. The interviews are held over Zoom or MS Teams. If you would like to discuss your interview with TechPros.io or our sponsor HCL Technologies before participating, please email firstname.lastname@example.org with the theme you have been invited to interview for and a number to call you.
Background reading to set some context for the interview:
See 2 example questions:
Reducing the time to market window for approved products clearly brings benefits – including reducing costs and, most importantly, saving patient lives.
What strategies has your organisation undertaken to enable faster, more agile supply chains whilst maintaining supply chain integrity in the face of (understandable) pressures to reduce time to market?
The life sciences industry operates in one of the world’s most regulated environments, and effectively managing regulation and compliance across multiple jurisdictions can be a point of strategic advantage.
Given the pressure to accelerate the time to market, how do you maintain and manage regulatory compliance?